BioRestorative Therapies, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
BioRestorative Therapies, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • BioRestorative Therapies, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.09M, a 123% decline year-over-year.
  • BioRestorative Therapies, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$9.65M, a 16.6% increase year-over-year.
  • BioRestorative Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.4M, a 21.2% increase from 2022.
  • BioRestorative Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.2M, a 70.2% increase from 2021.
  • BioRestorative Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$44.3M, a 293% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$9.65M -$1.09M -$5.86M -123% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$3.79M -$4.03M +$1.68M +29.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$5.47M -$2.22M +$4.95M +69% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$10.4M -$2.3M +$1.16M +33.4% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-06-11
Q3 2023 -$11.6M $4.77M +$9.42M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$21M -$5.71M -$8.81M -284% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$12.2M -$7.17M +$1.03M +12.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$13.2M -$3.46M +$16.9M +83% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-11
Q3 2022 -$4.66M -$472K -11.3% Sep 8, 2022 Sep 30, 2022 10-Q 2022-11-14
Q3 2022 -$30.2M -$5.45M -$1.26M -30.2% Jul 1, 2022 Sep 30, 2022 10-K/A 2024-06-11
Q2 2022 -$29.7M $3.1M +$7.16M Apr 1, 2022 Jun 30, 2022 10-K/A 2024-06-11
Q1 2022 -$36.9M -$8.21M +$7.45M +47.6% Jan 1, 2022 Mar 31, 2022 10-K/A 2024-06-11
Q4 2021 -$44.3M -$20.4M -$14.6M -254% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$29.7M -$4.18M -$3.35M -400% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$26.3M -$4.06M -$6.94M -241% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$19.4M -$15.7M -$8.1M -107% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$11.3M -$5.76M -$4.21M -272% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$7.06M -$836K +$4.22M +83.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$11.3M $2.88M +$7.03M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$18.3M -$7.55M -$3.67M -94.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$14.6M -$1.55M +$2.02M +56.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-30
Q3 2019 -$16.7M -$5.06M -$2.13M -72.9% Jul 1, 2019 Sep 30, 2019 10-Q 2021-04-12
Q2 2019 -$14.5M -$4.16M -$643K -18.3% Apr 1, 2019 Jun 30, 2019 10-Q 2021-04-12
Q1 2019 -$13.9M -$3.88M -$1.38M -54.9% Jan 1, 2019 Mar 31, 2019 10-Q 2021-04-12
Q4 2018 -$12.5M -$3.57M -$1.71M -92% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 -$10.8M -$2.93M -$873K -42.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$9.93M -$3.51M -$767K -27.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$9.17M -$2.51M +$278K +9.98% Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-14
Q4 2017 -$9.44M -$1.86M +$197K +9.58% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$9.64M -$2.05M -$218K -11.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$9.42M -$2.75M -$489K -21.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$8.93M -$2.79M -$298K -12% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$8.64M -$2.06M +$1.06M +34.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$9.7M -$1.83M -$210K -12.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$9.49M -$2.26M -$838K -59% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$8.65M -$2.49M -$727K -41.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$7.92M -$3.12M -$1.63M -110% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$6.29M -$1.62M -$523K -47.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 -$5.77M -$1.42M -$87.2K -6.54% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$5.68M -$1.76M -$90.4K -5.42% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$5.59M -$1.48M +$147K +8.99% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$5.73M -$1.1M +$203K +15.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 -$5.94M -$1.33M -$81.9K -6.55% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$5.85M -$1.67M -$104K -6.62% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$5.75M -$1.63M +$288K +15% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$6.04M -$1.3M +$174K +11.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$6.21M -$1.25M +$395K +24% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$6.61M -$1.57M -$71.6K -4.79% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$6.54M -$1.92M -$1.18M -158% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-11
Q3 2012 -$5.36M -$1.48M -$464K -45.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-19
Q2 2012 -$4.9M -$1.65M -$441K -36.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 -$4.46M -$1.49M -$381K -34.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$4.07M -$743K Oct 1, 2011 Dec 31, 2011 10-K 2014-04-11
Q3 2011 -$1.01M -$625K -161% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 -$1.2M -$1.01M -511% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.11M Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-06-01
Q3 2010 -$389K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$197K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.